Actively Recruiting
NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment
Led by St. Justine's Hospital · Updated on 2024-04-19
124
Participants Needed
2
Research Sites
201 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.
CONDITIONS
Official Title
NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Preterm infants born between 24 and 33 6/7 weeks gestational age
- Infants ready for skin-to-skin contact (SSC)
- Mothers and fathers agree to perform at least one SSC session per week combined with 10 minutes of auditory stimulation until the infant reaches 36 weeks gestational age
- Mothers express breast milk for their preterm infants
- For twin births, fathers are invited to participate so both infants can be included
You will not qualify if you...
- Preterm infants with congenital anomalies or genetic disorders
- Preterm infants with intraventricular hemorrhage greater than grade II
- Infants who are small for gestational age, defined as birth weight below the 10th percentile
- Infants beyond postnatal day 19 at study start
- Infants still receiving analgesics, sedatives, or paralytic agents
- Infants under mechanical ventilation
- Mothers and fathers younger than 18 years
- Parents with physical conditions preventing skin-to-skin contact
- Parents who abuse illicit substances or alcohol affecting parent-child interactions
- Infants fed exclusively with commercial infant formula
- Mothers with breast surgery affecting milk production
- Parents who do not speak, read, or write in French or English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5
Actively Recruiting
2
CUSM
Montreal, Quebec, Canada, H4A 3J1
Not Yet Recruiting
Research Team
M
Marilyn Aita, Ph.D.
CONTACT
K
Kate St-Arneault, Ph.D (cand.)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here